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Summary The cytotoxic and stathomokinetic effects of vincristine (VCR) on murine fibrosarcoma (FSa)
cells, grown either in vitro as primary cultures or in vivo as micro- or macroscopic pulmonary nodules, were
determined and compared. FSa cells were separated and synchronized on the basis of size by centrifugal
elutriation. Flow microfluorometry (FMF) was used to determine the cell-cycle parameters and the relative
synchrony of the separated populations, thus allowing determination of age-dependent cytotoxicity. The
colony-forming efficiencies (CFE) of these cells were determined using a lung colony assay. Synchronized cell
population of FSa cells, separated by centrifugal elutriation, were injected into recipient animals and exposed
20min later to a single dose of VCR to determine their age-specific sensitivity. Under these conditions there
appeared to be a suggestion of an enhanced killing of cells enriched in the G2 +M phase. However, following
prolonged VCR exposure in vitro (e.g., 2.5pgml-1; 25ml for 24h) to primary cultures of FSa cells or in vivo
(e.g., 0.25mgkg-1 per fraction i.p.; 5 fractions in 24h) to macroscopic pulmonary tumour nodules, elutriated
FSa cell populations most enriched with G1 phase cells exhibited the lowest CFE. If under either condition
exposed cells were allowed to recover in the absence of VCR for 24h prior to their removal and separation,
FSa cell survival increased in each of the elutriated populations. In contrast, while G1 enriched cell
populations from in vitro exposed cultures still exhibited a significant reduction in CFE, no such age-specific
response was observed for in vivo exposed macroscopic pulmonary nodules. The stathomokinetic effect of
VCR on FSa cells was also readily observed in vitro using FMF analysis (e.g., an increase of from 20 to 38%
in the G2+M phase compartment). While no such effect was observed in vivo using FMF analysis, cluster of
mitotic figures were observed. The mitotic indices (MI) of the in vivo exposed FSa cells increased from 2.5 to
8.4%.
The principal mode of action of vincristine (VCR),
a member of the vinca alkaloids, at low
concentrations is through interference with
microtubulin polymerization and mitotic spindle
formation in mammalian cells, leading to cell arrest
in mitosis (Himes et al., 1976; Owellen et al., 1974).
The ability of VCR to arrest cells in metaphase,
however, does not always correlate with phase-
specific cytotoxic activity (Camplejohn, 1980).
Variations in the age response of mammalian cells
to VCR have been reported for several cell lines
including G1 phase sensitivity for P388 leukemia
cells (Hill & Whelan, 1981), S phase sensitivity for
hamster NIL8 cells (Csuka et al., 1980), and late S
and G2 phase sensitivity for human 3025 cells
(Wibe, 1980).
In the characterization of the phase-specific
cytotoxicity of antitumour agents such as VCR, the
relative cell-stage responses are routinely assayed
under in vitro conditions that do not simulate the
complex conditions existing in vivo. It is
advantageous, therefore, to be able to evaluate the
phase-specific cytotoxic effectiveness of
chemotherapeutic agents such as VCR on selected
target cells in vivo, as well as in vitro.
In this communication we describe the cytotoxic
effectiveness of VCR on murine FSa cells following
prolonged exposure under in vitro or in vivo
conditions. The design of the experimental protocol
is presented in Figure 1 and is based on techniques
described elsewhere (Grdina et al., 1979; 1980;
Grdina, 1982) to characterize phase-specific
antitumour agents under both in vitro and in vivo
conditions.
Materials and methods
Mice and tumour
Female C3Hf/Kam mice, 10-12 weeks old, from
our specific pathogen-free breeding colony, and a
methylcholanthrene-induced fibrosarcoma were
used in these experiments (Suit & Suchato, 1967).
Tumours, sixth generation isotransplants, were
made into viable cell suspensions and either
cultured in vitro (Grdina et al., 1978a) or injected
into untreated recipient mice to give rise in 13 days
to 100-150 visible pulmonary nodules (Grdina et
al., 1978b).
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Tumour cell suspension
Single cell suspensions were prepared from
pulmonary tissue and tumour nodules according to
a method described in detail elsewhere (Grdina,
1982). Since no advantage has been observed
following the tedious excision of each individual
tumour nodule from the surrounding lung tissue,
entire tumour-bearing lungs were minced and
digested with trypsin (Grdina, 1982). Following this
procedure, lung tissue floated to the surface and the
highly enriched but undigested tumour tissue settled
to the bottom of the beaker. Viable tumour cells in
single-cell suspension were collected in the upper
two-thirds of the suspension mixture. Cell viability
determined by phase-contrast microscopy was
routinely >95%. The yield of viable tumour cells
was about 8.5 x 107g- tissue (Grdina & Hunter,
1982).
Culture conditions
FSa tumour cells were cultured in vitro under
conditions described in detail elsewhere (Grdina et
al., 1982a). Viable cells 1.5 x 107, were seeded into
32-ounce glass culture bottles, 20 bottles per
experiment, and incubated at 37°C in a water-
saturated atmosphere of 5% CO2 and air. The
growth medium was a modified McCoy's 5A
medium supplemented with 20% foetal calf serum
(Humphrey et al., 1970). After a 24h incubation,
the supernatant containing floating cells was
discarded and 20ml of fresh medium was added to
each culture bottle. The attached tumour cells were
then-incubated for an additional 24h prior to drug
exposure.
Cell separation (see Figure 1)
FSa cells derived directly from pulmonary nodules
or following growth in vitro were separated by
centrifugal elutriation (Grdina et al., 1978a; Grdina,
1982). Elutriation was performed using a Beckman
JE-6 elutriator rotor and a standard Beckman
chamber. This system and all of the associated
tubing were sterilized with 70% ethanol and
maintained at 4°C. The separation medium was a
modified McCoy's 5A supplemented with 5% foetal
calf serum containing DNase (Deoxyribonuclease 1;
Sigma Chemical Co., St. Louis, MO) at a final
concentration of 0.1 mgml -1 and 5mM 2-naphthol
6-8 disulphonic acid to reduce cell clumping
(Shortman, 1973). With a rotor speed of
1525revmin-1, between 2 x 108 and 3 x 108 cells,
suspended in 20ml of medium were introduced into
the elutriator chamber of a flow rate of
5.4mlmin-1. The rotor speed was held constant
throughout the separation, and the flow rates were
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Figure 1 Experimental protocols describing in vitro
and in vivo experiments performed to characterize the
effectiveness ofVCR on FSa tumour cells.
varied by equal increments from 5.4 to
27.4mlmin-1. Twelve 50ml fractions (F) were
collected and stored at 4°C. Cells collected in each
fraction were counted by haemacytometer and by
Coulter counter (model ZBI, Coulter Electronics,
Hialeah, FL). Fl, containing small cells and cellular
debris, and F12, containing a heterogeneous
mixture ofcells, were discarded.AGE RESPONSE OF FSa CELLS TO VINCRISTINE 281
Flow microfluorometry
The DNA content of individual cells in suspensions
was measured by flow microfluorometry (FMF)
using an ICPII flow cytometer (Phywe Co.,
Gottigen, Germany). Cells were fixed in 70%
ethanol and stained with 50mgml-1 mithramycin
(Mithracin, Chas. Pfizer and Co., Inc., New York,
NY) in a solution containing 7.5mM MgCl2 and
12.5% aqueous ethanol (Grdina et al., 1982a). the
resultant histograms of DNA fluorescence were
computer analyzed (Johnston et al., 1978). Since
FSa cells are heteroploid (i.e., 60-70 chromosomes)
and contain about 1.8 times as much DNA as normal
diploid cells, an estimate of the normal cell
contamination in each of the tumour-cell
suspensions was made by determining the area
under the G1 normal and dividing it by the area
under the entire FMF histogram (Grdina, 1982;
Grdina & Hunter, 1982). All cell counts used for
the clonogenicity assays were adjusted to represent
only tumour-cell numbers.
Mitotic index
The ability of VCR to arrest tumour cells in mitosis
following prolonged in vivo exposure was
determined. Five fractions, 0.25mgkg-1 each, of
VCR administered i.p. at 6h intervals. Mitotic
figures were scored in 3 mice per group at 3, 4, 18,
and 25h following the last injection. Following
sacrifice and excision, tumour-bearing lungs were
fixed in neutral buffered formalin for 48h. Five-pm
histological sections were prepared, mounted, and
stained. Five to 10 tumour nodules per mouse, in
which the vascular supply was clearly visible, were
selected. At 1000 x magnification, 5 microscope
fields adjacent to and surrounding the vascular
surface were examined for the number of mitotic
figures per total number of cells. Mitotic figures
were determined by counting a minimum of 1500
cells per experimental point.
VCR exposure in vitro
Stock solutions of vincristine sulfate (Oncovin),
obtained from the Eli Lilly Co., Indianapolis, IN,
were made up in bacteriostatic sodium chloride
solution at a concentration of 0.1 mgml-1I
FSa cells derived from pulmonary nodules were
grown in vitro for 48h prior to exposure to drug.
At that time, the media was changed and the
attached cells were exposed to a 2.5pgml-1
concentration of VCR (25ml/bottle) for either 4 or
24h. Following exposure, the cells were washed free
of VCR and either immediately harvested and
separated by centrifugal elutriation or allowed to
remain in culture for an additional 24h before
harvesting and separation.
VCR exposure in vivo
Two experimental protocols were used to evaluate
the effectiveness of VCR in vivo. In all studies at
least two reproducible experiments were performed.
The effectiveness of a single dose of 1 mgkg-1
VCR was evaluated on FSa cells recently trapped
in the lungs of test animals. Prior to drug
treatment, FSa cells grown as pulmonary nodules
were harvested, made into single-cell suspensions,
and separated by centrifugal elutriation into
subpopulations of cells enriched in G1, S, or
G2+M phase (Grdina et al., 1979; 1980; Grdina,
1982). Known numbers of viable cells from each of
these fractions were then injected i.v. into
corresponding groups of recipient animals, 20 mice
per group. Twenty minutes after injection of the
tumour cells, 10 mice in each group were injected
i.p. with VCR. Thirteen days later the animals were
sacrificed, and the resulting colonies in control and
treated groups were counted and compared (Grdina
et al., 1979; 1980; Grdina, 1982).
The effect of multiple doses of VCR on cell
killing was determined using mice bearing 13-day-
old pulmonary nodules. Thirty experimental
animals having from 100-150 pulmonary nodules
were injected i.p. with 5 fractions of VCR at a dose
of 0.25mgkg-1 per fraction. Injections were made
at 6h intervals. Either 1 or 24h after the last
injection, animals were sacrificed and their lungs
were removed. Suspensions of FSa cells were made
and separated by centrifugal elutriation. The CFE
of these cells was determined and compared to
corresponding untreated controls using a lung
colony assay (Grdina, 1982; Grdina & Hunter,
1982).
Lung colony assay
The CFE of FSa cells was determined in a lung
colony assay. Recipient mice, with their hind legs
shielded, were whole-body irradiated with 10Gy
24h before use. These mice were then injected with
known numbers of viable FSa cells, corrected for
normal cell contamination from each of the
elutriator fractions and the unseparated control cell
(USC) population. Each aliquot of cells also
contained 2 x 106 heavily irradiated (HIR) (100Gy)
FSa cells. HIR cells were not separated by
centrifugal elutriation. Thirteen days after the mice
were killed, their lungs were removed, the lobes
separated and fixed in Bouin's solution, and
tumour colonies counted.
Results
The recovery of cells following centrifugal
elutriation was routinely >90%, and the viability282 D.J. GRDINA et al.
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Figure 2 Percentage of FSa tumour cells, derived from pulmonary metastases, distributed among the various
cell-cycle phases plotted as a function ofelutriator fraction number. (0) G; (AL) S; (C]) G2+m.
of these cells, determined by phase contrast
microscopy, was >95%. Using a lung colony
assay, the CFE of untreated cells collected from
each of the elutriator fractions ranged from 1-3%.
Surviving fractions were determined by comparing
the CFE's of untreated cells from each of the
elutriator fractions with those of corresponding
treated groups.
Presented for comparison in Figure 2 are
representative data describing the percentages of
tumour cells in G1, S, and G2+M phase, as
determined by FMF analysis, in each of the
elutriator fractions. In general, G1, S, and G2+M
cells were most enriched in fractions 2 through 4, 5
through 7, and 8 through 11, respectively. This type
of analysis was routinely performed following each
elutriation of cells. No difference was observed in
the relative cell cycle distribution of cells as a
function of elutriator fraction number between
control and treated cell populations.
To determine the possible magnitude of the
stathmokinetic effects of VCR on FSa cells, tumour
cells were exposed under in vitro conditions to a
dose of 6.25mg of VCR for 24h. Presented in
Figure 3 for comparison are representative FMF
profiles describing the DNA contents of control
and drug-treated cells. Under these conditions,
VCR gave rise to a 2-fold build-up of cells having
G2+M phase DNA contents.
To determine the phase specificity, if any, of
VCR, a single dose was administered 20min
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Figure 3 Representative FMF profiles of unseparated
FSa cell populations in vitro. (a) unexposed FSa
control population; G1(N) refers to normal diploid
lung cells in G1 (17%); G1(T) refers to tumour cells in
G1 (59%); G2+M(T) refers to tumour cells in G2+M
(20%) (b) FSa cells exposed to VCR for 24h; G1(N)
(16%), G1(T) (25%), and G2+M(T) (38%);
coefficients of variation of G1 tumour peak untreated
4%, treated 5%.
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following the injection and entrapment in the lungs
of elutriated FSa cells. Under these conditions,
VCR exhibited little, if any, cytotoxic effect (Figure
4). The USC population exhibited a surviving
fraction of 92%. However, cell populations
enriched in G2+M phase by elutriation (e.g.,
fractions 8-11) consistently showed a slightly
reduced survival when assayed in this manner in 3
separate experiments, suggesting a possible
sensitivity for these cells.
100
80
60
lf/20 min/14d
40
100
80
60
40
20 _
c
0
0
C
0'->
10
8
6
4
2
20 _
1
0.8
0.6
1 2 3 4 5 6 7 8 9 10 11
Fraction number
Figure 4 Percent surviving fraction of FSa cells to a
single dose of VCR elutriator fraction number. Twenty
min following the i.v. imjection of tumour cells,
1.0mgkg-1 of VCR was injected i.p. Error bars
represent of the mean.
The cytotoxic effectiveness of VCR following
prolonged exposure was also determined. FSa cells
were exposed first in vitro to the same
concentration of drug, but the exposure times were
either 4 or 24h. The ability of the treated
population to recover following VCR exposure was
also determined. Representative data are presented
in Figure 5.
Following exposure for 4h, elutriator fractions
most enriched in S phase cells appeared to be the
most resistant (Figure 5). USC exhibited a
surviving fraction of 30%. Exposure for 24h
reduced cell survival of the USC population to
2.5%. The greatest cell killing, however, was
observed in elutriator populations enriched in G,
phase cells.
Cell survival was enhanced in the USC
population (4.5% surviving fraction) and FSa
subpopulations collected in elutriator fractions 4-11
if VCR-exposed cells were incubated in drug-free
medium for 24h prior to elutriation. Notable
exceptions (i.e., no improvement in cell survival)
were observed for G1-enriched FSa cells collected in
fractions 2 and 3.
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Figure 5 Percent surviving fraction as a function of
elutriator fraction number of FSa cells following
exposure to VCR (2.5pgml- 1; 25ml per bottle) in vitro
for 4h/Oh (cells harvested immediately after exposure)
(m), 24h/Oh (cells harvested immediately) (A), and
24h/24h (cells harvested 24h following exposure) (0).
Following harvesting, FSa cells were separated by
centrifugal elutriation and CFE were determined using
a lung colony assay. Error bars represent of the
mean.
Following the characterization of the
stathmokinetic and cytotoxic effectiveness of VCR
against FSa cells in vitro, experiments were designed
to study the in vivo effectiveness of this agent. To
ensure a sufficient tumour mass for study, FSa cells
were grown in vivo for 13 days to form
macropulmonary nodules. Because of the large
tumour burden, and to approximate the exposure
times in vitro, VCR was administered to tumour-
bearing animals in five fractions (0.25mgkg-1 per
fraction) over a 24h period. Presented for
comparison in Figure 6 are representative FMF
profiles describing the DNA contents of FSa cells
derived from 13 day old pulmonary nodules that
were either untreated or treated. In contrast to the
data presented in Figure 3, no change in DNA
distribution was observed following VCR exposure
in vivo.
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Figure 6 Representative FMF profiles of unseparated
FSa cell populations in vivo. (a) unexposed control
FSa cells; G1(N) (35%), G1(T) (59%), and G2+M(T)
(15%). (b) FSa cells from tumour nodules exposed to
5F of VCR (0.25mgkg-1 per fraction) over a 24h
period; G1(N) (32%), G1(T) (61%), and G2+M(T)
(14%). Coefficients of variation of G1 tumour peak
untreated 6%, treated 5%. MI refers to mitotic index.
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Figure 7 Mean mitotic index of FSa cells exposed as
13-day-old pulmonary tumour nodules as a function of
time following 5 fractions (0.25mgkg-1 per fraction)
of VCR administered over a 24h period. Error bars
represent 1 of the mean.
Because of the inability to demonstrate a
stathmokinetic effect of VCR using FMF,
experiments were designed to evaluate the
effectivenss of this agent by measuring changes in
mitotic indices (MI) following exposure. Five
fractions of VCR (0.25mgkg-' per fraction) were
administered over a 24h period to repeat the
studies described earlier using FMF analysis. Under
these conditions, the mean MI of these cells
increased from 2 to 8 (Figure 7). The MI then
decreased as a function of time following the last
injection to values below that of control by 18 h.
To facilitate a comparison of the cytotoxic effects
of VCR on FSa cells following prolonged exposure
under both in vitro and in vivo conditions, VCR
was administered to tumour-bearing mice in 5
fractions over a 24h period. If animals were
sacrificed h following the last injection, cell
populations most enriched with G1 phase cells
exhibited the lowest surviving fractions. The USC
population had a surviving fraction of 42%. The
reduced clonogenicity of G1 enriched FSa
populations was not observed, however, if animals
were allowed to survive an additional 24h after
treatment. In contrast to the in vitro survival data
presented in Figure 5, elutriator fractions enriched
in G1 phase cells contained approximately the same
proportion of surviving cells as contained in the
remaining elutriator fractions (Figure 8) and the
USC population (surviving fraction of 68%).
Discussion
In earlier reports we described in detail procedures
by which chemotherapeutic agents could be
characterized in vivo with respect to phase
specificity in cell killing (Grdina et al., 1979; 1980).
Our results using hydroxyurea, adriamycin, cytosine
arabinoside, bleomycin, and cis-
diammindichloroplatinum were found to compare
favorably with those obtained under in vitro
conditions (Meyn et al., 1980).
Subsequent to these studies we characterized the
age response of FSa cells to ionizing radiation
under in vitro and in vivo conditions, the latter
either as single cells trapped in the lungs of mice or
as 14 day old pulmonary tumour nodules (Hunter
et al., 1979; Grdina & Hunter, 1982). Again, there
was excellent agreement in the qualitative age
response exhibited under either in vitro or in vivo
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00o suspensions or sedimentation profiles following the
80 ~; ,> separation of cells by centrifugal elutriation was /\ X + 4, observed between cell populations derived from
60 VCR-treated or untreated control FSa pulmonary
I \ -t7[ ~~~~~tumours. o / The stathmokinetic effect of VCR on FSa cells,
40 - as determined by FMF analysis, was mostly readily
demonstrable under in vitro conditions. In contrast,
little or no effect could be observed using FMF
following exposure of FSa cells by VCR in vivo.
/n! For this reason, MI were also determined for both
g 20 normal and malignant tissues. It was difficult to
'/ determine the MI of FSa lung nodules because
large areas in the tumour cross sections contained
either few or no mitotic figures or large clusters of
10 , , I I I mitotic cells, suggesting a non-unifrom exposure to
2 3 4 5 6 7 8 9 10 11 drug. MI determinations were performed, therefore,
Fraction number using capillaries in the tumour cross sections as
points of reference. The failure to observe a
Figure 8 Percent surviving fraction as a function of stathmokinetic effect of VCR in vivo using FMF
elutriator fraction number of FSa cells following was most probably due, therefore, to the large
prolonged in vivo exposure to VCR. Five fractions (f) background of unaffected or underexposed FSa
of VCR at a dose of 0.25mgkg-' were injected i.p. cells. The clustering of mitotic figures is most
Each dose was separated by 6h, and tumour-bearing probably indicative of the non-uniform distribution
animals were sacrificed at 1 h (0) or 24h () ofVCR.
following the last injection. Tumours were then °
excised, made into single cell suspensions, and cells An attempt was made to characterize the in vivo
were separated by centrifugal elutriation. CFE were phase cytotoxicity of VCR on FSa cells lodged in
determined using a lung colony assay. Error bars the lungs of mice. VCR administered as a single
represent 1 of the mean. dose in vivo was slightly more effective on FSa cells
injected from fractions 8-11 that from the other
elutriator fractions 2 to 5. However, because of the
conditions. These results support the efficacy of our relative small, albeit consistent, reduction in
in vivo procedure to characterize the phase specific absolute survival in these fractions, it is not clear
cytotoxicity of selected chemotherapeutic agents in whether this apparent relatively weak G2+M
vivo. We have applied this procedure to study not phase-specific response is significant or not.
only the effect of a single dose of VCR on tumour Following prolonged exposure in vitro to VCR,
cells in vivo, but also the cytotoxic and however, G1-enriched FSa cells collected in
stathmokinetic effects of either multiple exposures elutriator fractions 2 and 3 exhibited the lowest
in vivo or prolonged exposure in vitro. surviving fractions. The reduced CFE of cells in
FSa cells, derived from artificially induced these fractions after even a short exposure time of
pulmonary tumour nodules, were effectively 4h suggests that VCR may have been directly
separated by the method of centrifugal elutriation effective against cells in Gi. It is probable, however,
into subpopulations enriched in G1, S, and G2+M that some cells damaged in late G2 and M phase
phase cells. To ensure that potential changes in cell survived the division process and progressed to G1
size without concomitant changes in DNA content phase at the time of elutriation. This possibility
of treated cells would be monitored, FMF analysis may also explain the failure of cells in fractions 2
was performed on cells from each elutriation and 3 to increase in CFE after 24h of drug-free
fraction following separation. Under the conditions incubation following a 24h exposure, as compared
described, the response of FSa cells to VCR was to FSa cells elutriated immediately after exposure.
unchanged regardless of whether exposure was Cell progression along with other factors must be
before or after separation by centrifugal elutriation. considered in interpreting the survival data of FSa
Similar results with respect to the lack of an effect cells exposed over a 24h period in vivo. During this
exerted by the method of centrifugal elutriation on period, the mitotic index in the FSa lung nodules
the age response of separated cells has been increased from 1.2-5.5% as a result of the
reported by others (Keng & Wheeler, 1980; Grdina stathmokinetic effect of VCR. In good agreement
& Hunter, 1982). with the in vitro studies, the greatest reduction in
No discernible difference with respect to either CFE was observed in G1-enriched FSa cells
cell yield following the preparation of single-cell collected in elutriator fractions 2 and 3 if animals286 D.J. GRDINA et al.
were sacrificed 1 h following the last exposure.
These data again suggest that some damaged cells
progressed through the mitotic block and
accumulated in G1 at the time the animals were
sacrificed. These data do not preclude the
possibility that some VCR-arrested cells underwent
endoreduplication and became multinucleate cells
(Alabaster & Cassidy, 1978; Hartenstein et al.,
1973). Cells such as these would, however, be
relatively large and would, therefore, have been
collected in elutriator fractions 10-12. These cells
would not have DNA contents characteristic of G1
phase cells.
The major difference between the cell survival
data acquired in vitro and in vivo was observed for
VCR-treated animals that were allowed to survive
an additional 24h following exposure. Under in
vivo conditions little or no difference in surviving
fraction was apparent between the elutriated
populations. Specifically, populations enriched in
G1 phase cells exhibited no selective reduction in
CFE. The failure to exhibit G1 sensitivity under
this in vivo condition may be due to several factors.
VCR-damaged cells in vivo may be selectively
removed by host surveillance mechanisms. Since
elutriation occurs 24h following treatment,
sufficient time would be available for the selective
removal of damaged cells. Secondly GO-like
nonproliferating FSa cells may be recruited
following VCR exposure. These cells, presumably
undamaged, could then enter into the progression
cycle and, in a manner, dilute the number of VCR-
damaged clonogens present 24h after treatment.
Unfortunately, these quiescent cells cannot be
readily identified in the FSa tumour system by two
parameter FCM methods (Brock et al., 1982). Their
presence is strongly suggested, however, from DNA
precursor labelling data presented elsewhere
(Sigdestad & Grdina, 1981; Brock et al., 1982).
Thirdly, repair of VCR-induced damage may be
more efficient under in vivo as compared to in vitro
conditions. In particular, a selected cohort of cells
in the pulmonary tumours might, in contrast to
cells growing in vitro, be capable of repairing
chemically-produced potentially lethal damage. Any
or all of these factors could lead to the observed
reduced cytotoxic effect of VCR on G1 enriched
populations in vivo.
In conclusion, we have characterized the response
of FSa cells to VCR grown either as in vitro
monolayer cultures or as in vivo pulmonary tumour
nodules. The response of these cells to prolonged
exposure to VCR was comparable under both
conditions only if elutriation and CFE were
determined immediately following prolonged
treatment. Cell populations recovered following
elutriation, which were enriched in G1 phase cells,
exhibited the lower CFE. This may have been due
to both direct killing of G1 phase cells, and the
progression of damaged G2+M phase cells into the
G1 compartment prior to elutriation. If cells were
allowed to recover for 24h following treatment,
CFE was increased for S and G2+M phase cells
under both in vivo and in vitro conditions. Only
populations enriched in G1 phase cells responded
differently. These data demonstrate that in vitro-
devised experiments may not always reflect the in
vivo kinetic and clonogenic response of target cells
to chemotherapeutic agents such as VCR. Through
the use of centrifugal elutriation and artifical
metastases systems, such as single cells lodged in
the lungs (i.e., micrometastases) or 13 day old
pulmonary nodules (i.e., macrometastases), the
therapeutic effectiveness of selected modalities,
either alone or in combination, can routinely and
rapidly evaluated.
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